Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-29 Purchase | 2024-09-03 5:38 pm | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 154,500 | $0.69498 | $107,375 | 843,941 (Direct) | View |
| 2023-08-10 Purchase | 2023-08-11 4:15 pm | Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer | 88,000 | $1.26 | $110,880 | 448,911 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-09 6:23 pm | Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer | 80,000 | $1.24 | $99,200 | 360,911 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-02 5:50 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A 2022-03-27 | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 240,530 | $0 | 1,255,302 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 149,999 | $0.94 | 1,255,302 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 90,531 | $0.55 | 1,255,302 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-02 6:37 pm | N/A 2033-01-31 | Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2022-05-19 Option Award(A) | 2022-05-27 5:35 pm | N/A N/A | Cortexyme Inc. | CRTX | Thye Dirk Chief Executive Officer | 216,322 | $0 | 280,911 (Direct) | View |
| 2022-05-19 Option Award | 2022-05-23 8:29 pm | N/A 2022-03-27 | Cortexyme Inc. | CRTX | Thye Dirk Chief Executive Officer | 2,250,630 | $0 | 2,250,630 (Direct) | View |